Nociceptin and the ORL-1 ligand [Phe1Ψ(CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1252-1258

  Bertorelli, Rosalia ^a   Corradini, Laura ^a   Rafiq, Kamran ^a,c   Tupper, Joanna ^a,c   Calò, Girolamo ^b   Ongini, Ennio ^a  

^a San Raffaele Science Park   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chronic pain; Freund's adjuvant arthritis; Hyperalgesia; Nociceptin; Phe1 (CH2 NH)Gly2 NC(1 13)NH2

Indexed keywords

FREUND ADJUVANT; MORPHINE; NOCICEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CHRONIC PAIN; HYPERALGESIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032715457     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702884     Document Type: Article

References (42)

1. ANDOH, T., ITOH, M. & KURAISHI, Y. (1997a). Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. Neuroreport, 8, 2793-2796.
2. ANDOH, T., ITOH, M. & KURAISHI, Y. (1997b). Expression and tissue distribution of prepronociceptin messenger RNA in rats with adjuvant-induced hyperalgesia. Soc. Neurosci., 704.10 (Abstract).
3. BIGONI, R., GIULIANI, S., CALO', G., RIZZI, A., GUERRINI, R., SALVADORI, S., REGOLI, D. & MAGGI, C.A. (1999). Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 160-167.
4. BUTLER, S.H., GODEFROY, F., BESSON, J.M. & WEIL-FUGAZZA, J. (1992). A limited arthritic model for chronic pain studies in the rat. Pain, 48, 73-81.
5. 2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol., 349, R5-R6.
6. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J. Med. Chem., 41, 3360-3366.
7. CALO', G., RIZZI, A., MARZOLA, G., GUERRINI, R., SALVADORI, S., BEANI, L., REGOLI, D. & BIANCHI, C. (1998b). Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol., 125, 373-378.
8. CARPENTER, K.J. & DICKENSON, A.H. (1998). Evidence that a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br. J. Pharmacol., 125, 949-951.
9. DARLAND, T., HEINRICHER, M.M. & GRANDY, D.K. (1998). Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci., 21, 215-221.
10. DAWSON-BASOA, M. & GINTZLER, A.R. (1997). Nociceptin (orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociception and induces hyperalgesia. Brain Res., 750, 48-52.
11. ERB, K., LIEBEL, J.T., TEGEDER, I., ZEILHOFER, H.U., BRUNE, K. & GEISSLINGER, G. (1997). Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. Neuroreport, 8, 1967-1970.
12. FABER, E.S., CHAMBERS, J.P., EVANS, R.H. & HENDERSON, G. (1996). Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br. J. Pharmacol., 119, 189-190.
13. GOFF, J.R., BURKEY, A.R., GOFF, D.J. & JASMIN, L. (1998). Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience, 82, 559-574.
14. GRISEL, J.E., MOGIL, J.S., BELKNAP, J.K. & GRANDY, D.K. (1996). Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport, 7, 2125-2129.
15. GUERRINI, R., CALO', G., RIZZI, A., BIANCHI, C., LAZARUS, L.H., SALVADORI, S., TEMUSSI, P.A. & REGOLI, D. (1997). Address and message sequences for the NC receptor: a structure-activity study of NC-(1-13)-peptide amide. J. Med. Chem., 40, 1789-1793.
16. GUERRINI, R., CALO', G., RIZZI, A., BIGONI, R., BIANCHI, C., SALVADORI, S. & REGOLI, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163-165.
17. HAD, J.X., XU, I.S., WIESENFELD-HALLIN, Z. & XU, X.J. (1998). Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain, 76, 385-393.
18. HAO, J.X., WIESENFELD HALLIN, Z. & XU, X.J. (1997). Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci. Lett., 223, 49-52.
19. HARA, N., MINAMI, T., OKUDA ASHITAKA, E., SUGIMOTO, T., SAKAI, M., ONAKA, M., MORI, H., IMANISHI, T., SHINGU, K. & ITO, S. (1997). Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br. J. Pharmacol., 121, 401-408.
20. HARGREAVES, K., DUBNER, R., BROWN, F., FLORES, C. & JORIS, J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
21. HAY, C.H., TREVETHICK, M.A., WHEELDON, A., BOWERS, J.S. & DE BELLEROCHE, J.S. (1997). The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience, 78, 843-850.
22. HENDERSON, G. & MCKNIGHT, A.T. (1997). The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmacol. Sci., 18, 293-300.
23. JIA, Y.P., LINDEN, D.R., SERIE, J.R. & SEYBOLD, V.S. (1998). Peripheral inflammation increases nociceptin/orphanin FQ binding in the superficial laminae of the rat spinal cord. Soc. Neurosci., 350.2(Abstract).
24. LIEBEL, J.T., SWANDULLA, D. & ZEILHOFER, H.U. (1997). Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurones of the neonatal rat spinal cord. Br. J. Pharmacol., 121, 425-432.
25. MADEDDU, P., SALIS, M.B., MILIA, A.F., EMANUELI, C., GUERRINI, R., REGOLI, D. & CALO', G. (1999). Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension, 33, 914-919.
26. MAEKAWA, K., MASABUMI, M., TAKAHIRO, M. & SATOH, M. (1995). Expression of mu and kappa, but not delta, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats. Pain, 64, 365-371.
27. MEUNIER, J.C. (1997). Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol., 340, 1-15.
28. MEUNIER, J.C., MOLLEREAU, C., TOLL, L., SUAUDEAU, C., MOISAND, C., ALVINERIE, P., BUTOUR, J.L., GUILLEMOT, J.C., FERRARA, P. & MONSARRAT, B. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532-535.
29. MOGIL, J.S., GRISEL, J.E., REINSCHEID, R.K., CIVELLI, O., BELKNAP, J.K. & GRANDY, D.K. (1996). Orphanin FQ is a functional anti-opioid peptide. Neuroscience, 75, 333-337.
30. NISHI, M., HOUTANI, T., NODA, Y., MAMIYA, T., SATO, K., DOI, T., KUNO, J., TAKESHIMA, H., NUKADA, T., NABESHIMA, T., YAMASHITA, T., NODA, T. & SUGIMOTO, T. (1997). Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J., 16, 1858-1864.
31. PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic coordinates. Academic Press: New York.
32. REINSCHEID, R.K., NOTHACKER, H.P., BOURSON, A., ARDATI, A., HENNINGSEN, R.A., BUNZOW, J.R., GRANDY, D.K., LANGEN, H., MONSMA, F.J., JR. & CIVELLI, O. (1995). Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science, 270, 792-794.
33. RIZZI, A., CALO', G., TREVISANI, M., TOGNETTO, M., FABBRI, L., GUERRINI, R., SALVADORI, S., REGOLI, D. & GEPPETTI, P. (1999). Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus. Life Sci., 64, PL157-PL163.
34. SHAH, S., PAGE, C.P. & SPINA, D. (1998). Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br. J. Pharmacol., 125, 510-516.
35. TOLL, L., BURNSIDE, J. & BERZETEI-GURSKE, I. (1998). Agonist activity of the ORL1 antagonists is dependent upon receptor number. International Narcotics Research Conference, 20-25 July, Garmisch-Partenkirchen, Germany. A89. (Abstract).
36. WOOLF, C.J., ALLCHORNE, A., SAFIEH-GARABEDIAN, B. & POOLE, S. (1997). Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol., 121, 417-424.
37. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci. Lett., 249, 127-130.
38. XU, X.J., HAO, J.X. & WIESENFELD HALLIN, Z. (1996). Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport, 7, 2092-2094.
39. YAMAMOTO, T. & NOZAKI TAGUCHI, N. (1997). Effects of intrathecally administered nociceptin, an opioid receptor-like 1 receptor agonist, and N-methyl-D-aspartate receptor antagonists on the thermal hyperalgesia induced by partial sciatic nerve injury in the rat. Anesthesiology, 87, 1145-1152.
40. YAMAMOTO, T., NOZAKI TAGUCHI, N. & KIMURA, S. (1997a). Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by carrageenan injection into the rat paw. Brain Res., 754, 329-332.
41. YAMAMOTO, T., NOZAKI TAGUCHI, N. & KIMURA, S. (1997b). Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like receptor agonist, in the rat formalin test. Neuroscience, 81, 249-254.
42. YAMAMOTO, T., NOZAKI TAGUCHI, N. & KIMURA, S. (1997c). Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci. Lett., 224, 107-110.